UMI3 – The University of Manchester Innovation Group
Two of the key people at UMI3, The University of Manchester’s innovation company, are Dr Luke Hakes, Chairman, and Andrew Wilkinson, Chief Executive.
Chairman, Dr Luke Hakes
A triple graduate of the University in biochemistry with biotechnology; bioinformatics; and computational genetics, Luke completed his PhD in 2006. He is currently Investment Director at venture capital firm, Octopus Ventures, based in the City of London.
Over the last eight years Luke has advised and been a board member of a number of University spin-out companies. In addition he has held numerous non-executive directorships at start up and growth companies and has considerable experience of building and exiting businesses in the disruptive technology arena.
Outside of Octopus, Luke is an angel investor and adviser to a number of early-stage companies, with a particular interest in the artificial intelligence and genomics spaces.
CEO, Andrew Wilkinson
An alumnus of the University, Andrew is a successful CEO and Managing Director with extensive experience growing international technology companies. He spent many years leading complex, multi-national businesses, operating across a wide range of sectors. He specialises in the industrialisation and commercialisation of innovative technologies, business growth and turn-around.
Andrew joined the University in mid-2016 as CEO of its subsidiary company Graphene Enabled Systems Ltd (GES). Before joining GES, Andrew was Regional Managing Director of the French power equipment manufacturer Socomec SA. At Socomec, Andrew led three subsidiaries covering North America and the British Isles, where he significantly grew the businesses’ revenue, profitability and market share.
Prior to this, he was Sales and Marketing Director of a group business of ICI plc, which manufactured a broad range of industrial and consumer products based on coated and thermally stabilised PET film.
Visit the UMI3 website to find out more about our innovation and enterprise.